Back to Search
Start Over
Agonist-induced periodic vasomotion in rat isolated pulmonary artery.
- Source :
-
Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2011 Aug; Vol. 25 (4), pp. 443-51. Date of Electronic Publication: 2010 Sep 30. - Publication Year :
- 2011
-
Abstract
- Vasomotion is linked to the rapid oscillations of intracellular calcium levels. In rat pulmonary artery, this activity can manifest as a slow periodic on-off pattern, the timing of which depends on the type and intensity of pharmacological stimuli employed. In this study, we have sought to characterize a slow-wave vasomotor activity pattern induced in isolated arterial ring preparations by simultaneous exposure to the α(1) -adrenoceptor agonist phenylephrine (1-10 nm) and the L channel agonist S(-)-Bay K 8644 (3-20 nm). Treated tissues responded with a stable on-off pattern of vasomotion persisting for >5 h at 5-6 cycles/h. In intact rings, this response was suppressed by methacholine and restored or enhanced by N(ω) -nitro-l-arginine methyl ester. Analogous inhibitory effects were obtained with high Mg(2+) , 8-Br-cGMP (but not 8-Br-cAMP), riluzole, ryanodine, chelerythrine, and fasudil. Pinacidil (30 nm) increased off-cycle length without change in slow-wave amplitude. Conversely, tetraethylammonium (1.0-3.0 mm) augmented the latter without affecting periodicity. Carbenoxolone (10 μm) abolished slow-wave activity, while raising basal tone and inducing random phasic activity. In endothelium-denuded rings, the threshold of agonist-induced slow-wave vasomotion was lowered and a similar inhibitory effect obtained with carbenoxolone. In conclusion, the slow-wave pattern of vasomotion described here is (i) subject to inhibitory modulation by endothelial NO and an array of voltage-gated and leak K conductances yet to be fully characterized; (ii) dependent on Ca(2+) from both extracellular and sarcoendoplasmatic sources; (iii) controlled by kinase (Rho and PKC)-mediated regulation of myosin light chain phosphatase; and (iv) synchronized via intermyocyte gap junctions.<br /> (© 2010 The Authors Fundamental and Clinical Pharmacology © 2010 Société Française de Pharmacologie et de Thérapeutique.)
- Subjects :
- 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine analogs & derivatives
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine pharmacology
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester pharmacology
8-Bromo Cyclic Adenosine Monophosphate pharmacology
Animals
Benzophenanthridines pharmacology
Calcium Signaling drug effects
Calcium Signaling physiology
Carbenoxolone pharmacology
Cyclic GMP analogs & derivatives
Cyclic GMP pharmacology
Cyclic GMP-Dependent Protein Kinases antagonists & inhibitors
Endothelium, Vascular drug effects
Endothelium, Vascular physiology
Gap Junctions drug effects
Gap Junctions physiology
In Vitro Techniques
Male
Methacholine Chloride pharmacology
Muscle, Smooth, Vascular drug effects
NG-Nitroarginine Methyl Ester pharmacology
Phenylephrine pharmacology
Pinacidil pharmacology
Potassium Channels agonists
Potassium Channels physiology
Protein Kinase C antagonists & inhibitors
Protein Kinase Inhibitors pharmacology
Pulmonary Artery drug effects
Rats
Rats, Sprague-Dawley
Riluzole pharmacology
Ryanodine pharmacology
Tetraethylammonium pharmacology
Adrenergic alpha-1 Receptor Agonists pharmacology
Calcium Channel Agonists pharmacology
Muscle, Smooth, Vascular physiology
Pulmonary Artery physiology
Vasomotor System physiology
Subjects
Details
- Language :
- English
- ISSN :
- 1472-8206
- Volume :
- 25
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Fundamental & clinical pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 20880385
- Full Text :
- https://doi.org/10.1111/j.1472-8206.2010.00878.x